Cargando…
Role of protein kinase CK2 in antitumor drug resistance
Drug resistance represents the major reason of pharmacological treatment failure. It is supported by a broad spectrum of mechanisms, whose molecular bases have been frequently correlated to aberrant protein phosphorylation. CK2 is a constitutively active protein kinase which phosphorylates hundreds...
Autores principales: | Borgo, Christian, Ruzzene, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612148/ https://www.ncbi.nlm.nih.gov/pubmed/31277672 http://dx.doi.org/10.1186/s13046-019-1292-y |
Ejemplares similares
-
Protein kinase CK2: a potential therapeutic target for diverse human diseases
por: Borgo, Christian, et al.
Publicado: (2021) -
Effects of the CK2 Inhibitors CX-4945 and CX-5011 on Drug-Resistant Cells
por: Zanin, Sofia, et al.
Publicado: (2012) -
Targeting CK2 in cancer: a valuable strategy or a waste of time?
por: Salvi, Mauro, et al.
Publicado: (2021) -
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells
por: Di Maira, Giovanni, et al.
Publicado: (2019) -
Antitumoral activity of allosteric inhibitors of protein kinase CK2
por: Moucadel, Virginie, et al.
Publicado: (2011)